Bivalirudin versus heparin and provisional GP IIb/IIIa inhibitors in patients treated for ST ‐segment elevation myocardial infarctions: Comparison of outcomes in a “real‐world” setting

ConclusionsIn this “real‐world” cohort of patients with STEMI bivalirudin compared to heparin and GPIs was associated with less bleedings and no significant differences in stent thromboses, reinfarctions, and mortality during hospital and long‐term course.

Source: Journal of Interventional Cardiology - June 7, 2017 Category: Cardiology Authors: Andreas Fach, Tina Backhaus, Johannes Schmucker, Robert Zabrocki, Daniela Garstka, Janina Stehmeier, Eduard Fiehn, Rainer Hambrecht, Harm Wienbergen Tags: ORIGINAL INVESTIGATION Source Type: research